Immunology
Global

Immunology Experts

Benoit Bouche Ph.d. Amp

President and CEO
immunology
NeoMed
Gambia

Biography

Benoit spent over 30 years on growing healthcare businesses and, solving fast growth-related issues as an entrepreneur, advisor and deal maker, or independent board member. He has an unrivaled experience in pharmaceutical outsourcing. He created and led an advisory firm, a central lab, and a clinical project monitoring unit, the three business units of what became the leading clinical stage CRO in Continental Europe in the late nineties with over 400 people, mainly located in France, Italy, and Germany. He is a board member at Mapi Group, then a late phase CRO with few tens of people and today the world leader in late phase patient-centered research with 800 people and revenues north of €100m. He also is a managing partner at Trans Hit Bio, the reference human biological samples procurement for biomarker development purposes CRO. Benoit has a dual scientific (PharmD Pharmacy 1984; PhD Pharmaceutical Sciences/Biotechnology 1986) and business (Advanced Management Program Harvard Business School 2002) education. His professional background enabled him to get to know in details all aspects of a healthcare venture stage company and to favor understanding and collaboration between scientists and business persons.

Research Interest

Benoit spent over 30 years on growing healthcare businesses and, solving fast growth-related issues as an entrepreneur, advisor and deal maker, or independent board member. He has an unrivaled experience in pharmaceutical outsourcing. He created and led an advisory firm, a central lab, and a clinical project monitoring unit, the three business units of what became the leading clinical stage CRO in Continental Europe in the late nineties with over 400 people, mainly located in France, Italy, and Germany. He is a board member at Mapi Group, then a late phase CRO with few tens of people and today the world leader in late phase patient-centered research with 800 people and revenues north of €100m. He also is a managing partner at Trans Hit Bio, the reference human biological samples procurement for biomarker development purposes CRO. Benoit has a dual scientific (PharmD Pharmacy 1984; PhD Pharmaceutical Sciences/Biotechnology 1986) and business (Advanced Management Program Harvard Business School 2002) education. His professional background enabled him to get to know in details all aspects of a healthcare venture stage company and to favor understanding and collaboration between scientists and business persons.

Global Experts from Gambia

Global Experts in Subject